February 08, 2024
A Pennsylvania federal judge on Thursday trimmed a breach-of-contract claim from a biotech executive's lawsuit, but preserved the bulk of the complaint, which accuses CSL Behring of firing him to avoid having to pay him an incentive of up to $3 million for staying with CSL following an acquisition.